fact sheet

Survey Finds Variability in MS Treatment Preferences Among Individual Patients, and Among Stakeholder Groups


Real Endpoints, LLC (RE), a data analytics firm focusing on assessing and quantifying pharmaceutical value, has completed an extensive literature review and survey to tease out how different stakeholder groups assess the value of current multiple sclerosis (MS) therapies.